wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42276735-74A97393-D051-43D7-83DD-F38A3C640CF8
Q42276735-74A97393-D051-43D7-83DD-F38A3C640CF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42276735-74A97393-D051-43D7-83DD-F38A3C640CF8
Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.
P2860
Q42276735-74A97393-D051-43D7-83DD-F38A3C640CF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42276735-74A97393-D051-43D7-83DD-F38A3C640CF8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47a8aa33af4c083fb38855c7404d2dad43dac12e
P2860
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.